The Revolution Rises
Pharma lags behind in the adoption of new technologies compared with other industries, but discussion around Industry 4.0 is increasing – and we are making progress.
Frank Cordes |
The fourth industrial revolution, Industry 4.0, is generating significant discussion in the biopharma industry, with a number of people believing that it is all hype. For me, however, Industry 4.0 is real and represents a period where we can integrate automation and information in a completely different way through kinetic systems. This could fundamentally change the production environment and redefine how factories work.
There are many technologies that fall into the category of Industry 4.0, but there are two that I am particularly excited about: predictive analytics and augmented reality. Predictive analytics are promising because our industry is flush with data that it does not take advantage of. Using predictive analytics, it will be possible to integrate data to teach machines to make predictions about the future, such as the future state of the product or the future flow of material, which can be used to steer the production environment. Imagine being able to use existing data to predict failure or delay at release. There is a huge opportunity for the industry to be more proactive in the production environment.
Enjoy our FREE content!
Log in or register to read this article in full and gain access to The Medicine Maker’s entire content archive. It’s FREE and always will be!
Login if you already created an account
Or register now - it’s free and always will be!
You will benefit from:
- Unlimited access to ALL articles
- News, interviews & opinions from leading industry experts
- Receive print (and PDF) copies of The Medicine Maker magazine